Codexis Inc (CDXS)
3.61
-0.16
(-4.24%)
USD |
NASDAQ |
May 17, 16:00
3.61
0.00 (0.00%)
After-Hours: 20:00
Codexis Cash from Operations (Quarterly): -7.789M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -7.789M |
December 31, 2023 | -11.04M |
September 30, 2023 | -16.30M |
June 30, 2023 | -16.09M |
March 31, 2023 | -9.212M |
December 31, 2022 | 4.917M |
September 30, 2022 | 19.73M |
June 30, 2022 | -2.181M |
March 31, 2022 | -11.19M |
December 31, 2021 | 0.66M |
September 30, 2021 | -0.192M |
June 30, 2021 | -8.295M |
March 31, 2021 | -6.44M |
December 31, 2020 | -1.492M |
September 30, 2020 | -3.474M |
June 30, 2020 | -10.07M |
March 31, 2020 | -1.425M |
December 31, 2019 | -3.661M |
September 30, 2019 | -0.99M |
June 30, 2019 | -5.058M |
March 31, 2019 | -2.851M |
December 31, 2018 | -0.72M |
September 30, 2018 | -1.233M |
June 30, 2018 | -7.956M |
March 31, 2018 | -4.185M |
Date | Value |
---|---|
December 31, 2017 | 7.626M |
September 30, 2017 | -4.85M |
June 30, 2017 | -7.965M |
March 31, 2017 | -3.566M |
December 31, 2016 | 5.163M |
September 30, 2016 | -7.21M |
June 30, 2016 | -0.032M |
March 31, 2016 | 0.219M |
December 31, 2015 | 7.156M |
September 30, 2015 | 0.431M |
June 30, 2015 | -4.172M |
March 31, 2015 | -3.848M |
December 31, 2014 | 4.974M |
September 30, 2014 | 1.686M |
June 30, 2014 | -3.934M |
March 31, 2014 | -2.405M |
December 31, 2013 | -3.905M |
September 30, 2013 | -8.533M |
June 30, 2013 | -7.073M |
March 31, 2013 | -3.487M |
December 31, 2012 | -4.737M |
September 30, 2012 | -3.863M |
June 30, 2012 | -3.885M |
March 31, 2012 | 0.593M |
December 31, 2011 | -2.896M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-16.30M
Minimum
Sep 2023
19.73M
Maximum
Sep 2022
-4.479M
Average
-4.360M
Median
Cash from Operations (Quarterly) Benchmarks
Avidity Biosciences Inc | -70.38M |
Taysha Gene Therapies Inc | -19.80M |
Janux Therapeutics Inc | -14.84M |
Tango Therapeutics Inc | -37.86M |
2seventy bio Inc | -41.88M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -28.56M |
Cash from Financing (Quarterly) | 29.28M |
Free Cash Flow | -54.22M |
Free Cash Flow Per Share (Quarterly) | -0.1277 |
Free Cash Flow to Equity (Quarterly) | -37.02M |
Free Cash Flow to Firm (Quarterly) | -8.919M |
Free Cash Flow Yield | -21.74% |